Monday broker round-up UPDATE

Abcam: Numis cuts target price from 510p to 490p and stays with its add rating.ARM Holdings: Credit Suisse reduces target price from 1200p to 1125p and maintains an outperform rating.AstraZeneca: Jefferies reduces target price from 4850p to 4790p maintaining a hold recommendation.BP: Credit Suisse moves target price from 495p to 505p and stays with its neutral rating.Debenhams: Numis upgrades from reduce to hold with a target price of 65p.GlaxoSmithKline: Jefferies reduces target price from 1610p to 1460p, while keeping a hold recommendation.Halfords Group: Numis upgrades from hold to add with a target price of 545p.Home Retail Group: UBS moves target price from 230p to 240p and reiterates a buy recommendation.Huntsworth: Numis places both its target price and its add rating under review.Inmarsat: Oriel initiates with a target price of 840p and an add rating.Progility: WH Ireland shifts target price from 11p to 12p staying with its buy recommendation.Royal Dutch Shell: Credit Suisse ups target price from 2550p to 2600p and retains an outperform rating.Smith (DS): Berenberg cuts target price from 400p to 350p keeping its buy recommendation.Synthomer: Deutsche Bank cuts target price from 245p to 225p and retains a hold recommendation. Numis upgrades from add to buy with a target price of 300p. Astrazeneca Hilton Foods Smith (DS) Synthomer Glaxosmithkline Home Reit